Remote Monitoring After Knee Replacement: AAOS 2026 Confirms It Works — Even for Older Patients

The Question That Wouldn't Go Away

Every time someone proposes remote monitoring for post-surgical patients, the same objection surfaces: "My patients are 70 years old. They can barely use their phone. This won't work."

It's a reasonable concern. The median age for total knee arthroplasty in the US is 68. Many patients are in their late 70s or 80s. Digital literacy is a documented barrier — the telerehab literature consistently flags it as a top-five challenge.

But new data presented at the American Academy of Orthopaedic Surgeons (AAOS) 2026 Annual Meeting in March directly addresses this objection — and the answer is unambiguous.

What AAOS 2026 Actually Showed

Researchers presented outcomes from deploying Remote Therapeutic Monitoring (RTM) after TKA, specifically examining safety and cost-effectiveness. The findings:

No increase in manipulation under anesthesia rates — the complication surgeons worry about most
No increase in reoperation rates — RTM patients did not have worse surgical outcomes
Decreased costs — remote monitoring reduced overall episode spending
Successful deployment in the geriatric population — this wasn't a cherry-picked cohort of tech-savvy 55-year-olds

That last point deserves emphasis. The researchers didn't exclude elderly patients. They specifically validated RTM in the population where skeptics said it wouldn't work.

Source: Healio Orthopedics, April 1, 2026

This Didn't Come Out of Nowhere

The AAOS data confirms what a growing body of evidence has been suggesting:

Telerehab is non-inferior to in-person rehab

A 2025 meta-analysis of 20 RCTs covering 3,706 TKA patients found no significant difference between telerehab and conventional physical therapy in pain (SMD -0.15, p=0.34) or physical function (SMD -0.04, p=0.62). The evidence base is large enough that "does telerehab work?" is no longer the right question. The right question is "how do we implement it well?"

Sources: JMIR 2025, JOSR 2025

Patients are more satisfied than expected

Despite initial preference for in-person care, 93.7–99% of patients report satisfaction once they actually use telerehab. 81.9% of TKA patients felt remote monitoring allowed their surgeon to closely track recovery. The objection is more about unfamiliarity than capability.

Adherence is higher, not lower

Digital rehab adherence runs 65–85%, compared to 40–60% for traditional home exercise programs. The data suggests that patients — including older ones — actually do better when they have structured digital guidance than when they're left alone with a printed exercise sheet.

The CMS Forcing Function

This evidence doesn't exist in a vacuum. Since January 1, 2026, the CMS TEAM model has made bundled payments mandatory for 741 hospitals. The model requires:

30-day episode tracking — hospitals are accountable for everything from surgery through one month post-discharge
PROM collection at scale — ≥50% matched pre/post completion rate by 2028
No infrastructure funding — CMS mandates the data, but doesn't pay for the collection systems

The math is straightforward. If you're accountable for 30-day outcomes and must collect PROMs, but your patient goes home the same day (51% of TKA procedures are now outpatient), you need a system that works outside the hospital.

Remote monitoring isn't a technology choice anymore. It's a compliance requirement.

The $3,200–$5,800 Question

A 2025 cost analysis showed that outpatient TKA with remote monitoring saves $3,200–$5,800 per episode compared to inpatient care, while maintaining equivalent outcomes.

For a hospital doing 500 joint replacements per year, that's $1.6M–$2.9M in annual savings. The RTM platform cost is a fraction of that.

The AAOS 2026 data adds the safety validation that was missing: you're not trading safety for savings. You're getting both.

What This Means for Practice

For surgeons

The geriatric validation is the key unlock. You no longer need to segment patients by age or perceived tech-savviness. The data says RTM works across the population you actually treat.

For hospital administrators

CMS TEAM is live. PROM collection is mandatory. Outpatient TKA is the norm. Remote monitoring is the connective tissue that makes all three work together. Every quarter you delay implementation is a quarter of untracked 30-day episodes.

For patients

The 93.7–99% satisfaction rate isn't because the technology is fun. It's because patients feel safer knowing their surgeon can see their recovery data between visits. For elderly patients especially, this eliminates the anxiety of "am I recovering normally?" that drives unnecessary ED visits and phone calls.

The Gap That Remains

The AAOS 2026 study validates RTM safety and cost-effectiveness, but it doesn't address the deeper question: what data should we actually be monitoring?

Most current RTM platforms track step counts, exercise completion, and PROMs. These are useful but surface-level. The next frontier is tissue-level data — forces across the implant, real-time load distribution, healing trajectory — that can detect problems before they manifest as symptoms.

This is where smart implant sensors (like Zimmer Biomet's Persona IQ) and next-generation force sensors are headed. The combination of remote monitoring infrastructure + implant-level data creates a closed-loop system where the technology doesn't just observe recovery — it actively guides clinical decisions.

The AAOS 2026 data proves the monitoring layer works. The sensor layer is next.